UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers

Oncology reports, 2013-07, Vol.30 (1), p.413-418

2013

Volltextzugriff (PDF)

Growth hormone-releasing hormone antagonists inhibit growth of human ovarian cancer

Hormone and metabolic research, 2011-10, Vol.43 (11), p.816-820

2011

Volltextzugriff (PDF)

Comparative Study of the Effects of PACAP in Young, Aging, and Castrated Males in a Rat Model of Parkinson's Disease

Annals of the New York Academy of Sciences, 2006-07, Vol.1070 (1), p.518-524

2006

Volltextzugriff (PDF)

Overall Experience of Two Clinical Trials for FUS-Mediated Blood Brain Barrier-Opening for Patients with DIPG/DMG Delivered in Radiation Oncology

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e725-e725

2024

Volltextzugriff (PDF)

New Antagonists of Growth Hormone Releasing Hormone (GHRH-A) Given after Radiation for Prostate Cancer Enhance Tumor Response Through Gene Regulation

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S649-S649

2010

Volltextzugriff (PDF)

Focused Ultrasound for Blood-Brain Barrier Opening and Delivery of Anti-PD1 in Diffuse Midline Gliomas

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e523-e524

2023

Volltextzugriff (PDF)

Inhibition of growth of HEC-1-A and HEC-1-B human endometrial cancer by growth hormone releasing hormone antagonist JMR-132

Gynecologic oncology, 2010-03, Vol.116 (3), p.596-596

2010

Volltextzugriff (PDF)

MP-02.04: Reduction in Prostate Size after Treatment with Cetrorelix in a Rat Model of Benign Prostatic Hyperplasia (BPH)

Urology (Ridgewood, N.J.), 2009, Vol.74 (4), p.S45-S45

2009

Volltextzugriff (PDF)

Radioprotection by Antagonists of Growth Hormone Releasing Hormone during Whole Body Radiation is Dependent on the Radiation Dose

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S552-S553

2009

Volltextzugriff (PDF)

Focused Ultrasound-Mediated Blood-Brain Barrier Opening Enhances Panobinostat Efficacy in a Murine Diffuse Intrinsic Pontine Glioma Model

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e177-e177

2021

Volltextzugriff (PDF)

Phase I dose-escalation study of the pan-PI3 K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors

European journal of cancer (1990), 2022-10, Vol.174, p.S28-S29

2022

Volltextzugriff (PDF)

Experimental therapy of ES-2 human platinum resistant ovarian cancer with targeted cytotoxic somatostatin and LHRH analogues

Gynecologic oncology, 2008-11, Vol.111 (2), p.376-376

2008

Volltextzugriff (PDF)

Neurological reflexes and early motor behavior in rats subjected to neonatal hypoxic–ischemic injury

Behavioural brain research, 2005-02, Vol.157 (1), p.157-165

2005

Volltextzugriff (PDF)

FLASH Modulation of Immune Microenvironment in Diffuse Midline Glioma (DMG) at Single-Cell Resolution

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.S127

2022

Volltextzugriff (PDF)

Development of neurological reflexes and motor coordination in rats neonatally treated with monosodium glutamate

Neurotoxicity research, 2005-11, Vol.8 (3-4), p.235-244

2005

Volltextzugriff (PDF)

Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson’s disease

Behavioural brain research, 2004-05, Vol.151 (1), p.303-312

2004

Volltextzugriff (PDF)

Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124]

Anti-cancer drugs, 2013-02, Vol.24 (2), p.150-157

2013

Volltextzugriff (PDF)

Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats

Behavioural brain research, 2005-03, Vol.158 (2), p.221-229

2005

Volltextzugriff (PDF)

Re: Shrinkage of Experimental Benign Prostatic Hyperplasia and Reduction of Prostatic Cell Volume by a Gastrin-Releasing Peptide Antagonist

The Journal of urology, 2013-11, Vol.190 (5), p.1956-1956

Kaplan, Steven A., M.D

2013

Volltextzugriff (PDF)

Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-II

Anti-cancer drugs, 2012-10, Vol.23 (9), p.906-913

2012

Volltextzugriff (PDF)

Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats

Regulatory peptides, 2004-12, Vol.123 (1-3), p.85-94

2004

Volltextzugriff (PDF)

Antagonists of growth hormone-releasing hormone potentiate radiation response in prostate cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10597-10597

2010

Volltextzugriff (PDF)

Effective treatment of triple-negative breast cancer with targeted cytotoxic somatostatin analogue AN-162 (AEZS-124)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.619-619

2009

Volltextzugriff (PDF)

Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals

Regulatory peptides, 2004-12, Vol.123 (1-3), p.51-59

2004

Volltextzugriff (PDF)

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases

Proceedings of the National Academy of Sciences - PNAS, 2012-01, Vol.109 (5), p.1655-1660

2012

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(58)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Animals
(33)
Life Sciences & Biomedicine
(32)
Humans
(29)
Male
(19)
Mice
(17)
Growth Hormone-Releasing Hormone - Antagonists & Inhibitors
(16)
Rats
(16)
Cell Line, Tumor
(15)
Mice, Nude
(15)
Sermorelin - Analogs & Derivatives
(12)
Oncology
(11)
Targeted Therapy
(11)
Biological And Medical Sciences
(10)
Cell Biology
(10)
Female
(10)
Endocrinology & Metabolism
(9)
Rats, Wistar
(9)
Growth Hormone-Releasing Hormone - Metabolism
(8)
Xenograft Model Antitumor Assays
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers

Growth hormone-releasing hormone antagonists inhibit growth of human ovarian cancer

Comparative Study of the Effects of PACAP in Young, Aging, and Castrated Males in a Rat Model of Parkinson's Disease

Overall Experience of Two Clinical Trials for FUS-Mediated Blood Brain Barrier-Opening for Patients with DIPG/DMG Delivered in Radiation Oncology

New Antagonists of Growth Hormone Releasing Hormone (GHRH-A) Given after Radiation for Prostate Cancer Enhance Tumor Response Through Gene Regulation

Focused Ultrasound for Blood-Brain Barrier Opening and Delivery of Anti-PD1 in Diffuse Midline Gliomas

Inhibition of growth of HEC-1-A and HEC-1-B human endometrial cancer by growth hormone releasing hormone antagonist JMR-132

MP-02.04: Reduction in Prostate Size after Treatment with Cetrorelix in a Rat Model of Benign Prostatic Hyperplasia (BPH)

Radioprotection by Antagonists of Growth Hormone Releasing Hormone during Whole Body Radiation is Dependent on the Radiation Dose

Focused Ultrasound-Mediated Blood-Brain Barrier Opening Enhances Panobinostat Efficacy in a Murine Diffuse Intrinsic Pontine Glioma Model

Phase I dose-escalation study of the pan-PI3 K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors

Experimental therapy of ES-2 human platinum resistant ovarian cancer with targeted cytotoxic somatostatin and LHRH analogues

Neurological reflexes and early motor behavior in rats subjected to neonatal hypoxic–ischemic injury

FLASH Modulation of Immune Microenvironment in Diffuse Midline Glioma (DMG) at Single-Cell Resolution

Development of neurological reflexes and motor coordination in rats neonatally treated with monosodium glutamate

Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson’s disease

Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124]

Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats

Re: Shrinkage of Experimental Benign Prostatic Hyperplasia and Reduction of Prostatic Cell Volume by a Gastrin-Releasing Peptide Antagonist

Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-II

Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats

Antagonists of growth hormone-releasing hormone potentiate radiation response in prostate cancer

Effective treatment of triple-negative breast cancer with targeted cytotoxic somatostatin analogue AN-162 (AEZS-124)

Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases

Suchergebnisse filtern